Trikafta’s Approval the Outcome of ‘20-year Journey That Started with a Dream’, Says Vertex CEO Jeffrey Leiden

The approval of Trikafta is the outcome of a “20-year journey that started with a dream,” according to Vertex CEO Jeffrey Leiden, MD.